100 related articles for article (PubMed ID: 18471963)
21. Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia.
Magwere T; Burchill SA
PLoS One; 2011; 6(12):e28558. PubMed ID: 22174837
[TBL] [Abstract][Full Text] [Related]
22. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation.
Sreenivasan Y; Sarkar A; Manna SK
Oncogene; 2003 Jul; 22(28):4356-69. PubMed ID: 12853972
[TBL] [Abstract][Full Text] [Related]
24. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
[TBL] [Abstract][Full Text] [Related]
25. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
Rundall BK; Denlinger CE; Jones DR
Surgery; 2004 Aug; 136(2):416-25. PubMed ID: 15300209
[TBL] [Abstract][Full Text] [Related]
26. R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.
Dey A; Wong ET; Cheok CF; Tergaonkar V; Lane DP
Cell Death Differ; 2008 Feb; 15(2):263-73. PubMed ID: 17975552
[TBL] [Abstract][Full Text] [Related]
27. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
Hermisson M; Weller M
Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
[TBL] [Abstract][Full Text] [Related]
28. HA14-1 sensitizes TNF-alpha-induced apoptosis via inhibition of the NF-kappaB signaling pathway: involvement of reactive oxygen species and JNK.
Moon DO; Kim MO; Kang SH; Choi YH; Park SY; Kim GY
Cancer Lett; 2010 Jun; 292(1):111-8. PubMed ID: 20022690
[TBL] [Abstract][Full Text] [Related]
29. Abrogation of NF-κB signaling in human neutrophils induces neutrophil survival through sustained p38-MAPK activation.
Langereis JD; Raaijmakers HA; Ulfman LH; Koenderman L
J Leukoc Biol; 2010 Oct; 88(4):655-64. PubMed ID: 20573801
[TBL] [Abstract][Full Text] [Related]
30. Characterization of signaling pathways leading to Fas expression induced by TNF-alpha: pivotal role of NF-kappaB.
Starace D; Riccioli A; D'Alessio A; Giampietri C; Petrungaro S; Galli R; Filippini A; Ziparo E; De Cesaris P
FASEB J; 2005 Mar; 19(3):473-5. PubMed ID: 15601669
[TBL] [Abstract][Full Text] [Related]
31. [The effects of endothelin 1 and an inhibitor of phosphorylation of IκB on the content of free sulfhydryl groups (-SH) and protein in rat kidney].
Gorąca A; Skibska B
Pol Merkur Lekarski; 2015 Apr; 38(226):203-5. PubMed ID: 25938386
[TBL] [Abstract][Full Text] [Related]
32. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
Ahn KS; Sethi G; Aggarwal BB
Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
[TBL] [Abstract][Full Text] [Related]
33. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells.
Javelaud D; Poupon MF; Wietzerbin J; Besançon F
Int J Cancer; 2002 Mar; 98(2):193-8. PubMed ID: 11857407
[TBL] [Abstract][Full Text] [Related]
35. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
[TBL] [Abstract][Full Text] [Related]
38. Influence of block of NF-kappa B signaling pathway on oxidative stress in the liver homogenates.
Kleniewska P; Piechota-Polanczyk A; Michalski L; Michalska M; Balcerczak E; Zebrowska M; Goraca A
Oxid Med Cell Longev; 2013; 2013():308358. PubMed ID: 23577221
[TBL] [Abstract][Full Text] [Related]
39. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment.
Mendoza FJ; Ishdorj G; Hu X; Gibson SB
Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578
[TBL] [Abstract][Full Text] [Related]
40. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.
Kim HJ; Lee HS; Chong YH; Kang JL
Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]